
Medexus Pharmaceuticals Inc.
Medexus Pharmaceuticals Inc. (MEDXF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MEDXF · as of Jun 9, 2026
Key Statistics
Explore Medexus Pharmaceuticals Inc. Data
medxf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
medxf competitorsStock Performance
Full HistoryAbout Medexus Pharmaceuticals Inc.
Medexus Pharmaceuticals Inc. is a specialized pharmaceutical firm conducting operations across both Canada and the United States. The company's therapeutic focus spans several critical domains, includ…
what is medexus pharmaceuticals inc. · medxf stock overview · medexus pharmaceuticals inc. company profile · who is medexus pharmaceuticals inc. ceo · medxf OTC · medexus pharmaceuticals inc. headquarters · medexus pharmaceuticals inc. business segments
About Stock Overview & Key Data
Medexus Pharmaceuticals Inc. (MEDXF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Nov 27, 2017. As of the latest trading session, MEDXF stock price is $2.78, with a market capitalization of $89.9M. The stock has returned +30.73% over the past 12 months and +31.97% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Medexus Pharmaceuticals Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Medexus Pharmaceuticals Inc. reported revenue of $108.3M and net income of $2.2M. For detailed data — including Medexus Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Medexus Pharmaceuticals Inc. (MEDXF) stock price is $2.78. The stock is traded on OTC under the ticker symbol MEDXF. The 52-week range is $1.80 – $3.04.